Anido Guides Aerie’s Push To Be A “Very Big Player” In Glaucoma - a podcast by OIS Podcast

Vicente Anido, Jr., PhD’s career has taken him through large companies and private start-ups. He’s taken life science companies public on two occasions, and he’s seen nearly every perspective of the ophthalmology industry. Today, Anido expects big things for Aerie Pharmaceuticals, a clinical-stage pharmaceutical company with two promising treatments for glaucoma in late clinical trials.

Further episodes of OIS Podcast | Ophthalmology

Further podcasts by OIS Podcast

Website of OIS Podcast